Heparin Market PPF 2021-2026: Size, Share, Trends, Analysis & Research Report

1. Global Heparin Market Research Report and Forecast 2021-2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Heparin Market Outlook 2026: As per the latest report by IMARC Group, titled “Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global heparin market size reached reached a value of US$ 6.7 Billion in 2020. Heparin (C12H19NO20S3) is an anticoagulant (blood thinner) that assists in preventing thromboembolic complications. In this complication, clots travel from their site of origin to clog up another vessel through the bloodstream. Heparin is generally injected into the muscle or the veins to break up clots and maintain the smooth fluidity of the blood. Therefore, it is utilized in the treatment of heart conditions and unstable angina. Besides this, it is also used in post-surgeries, and during dialysis and blood transfusion. Request for a free sample report: https://www.imarcgroup.com/heparin-market/requestsample

4. Report Description and Highlights Report Description Global Heparin Market Trends: The growing cases of vascular diseases, such as deep vein thrombosis (DVT) and pulmonary embolism (PE), represent one of the significant factors that are positively influencing the demand for heparin across the globe. Heparin has been proven to be an effective drug for venous thromboembolism and cardiovascular disorders (CVDs), which is also fueling the market growth. The market is also driven by numerous advancements in the field of carbohydrate synthesis, which include building block preparation, coupling reactions and the development of convergent strategies. Apart from this, the availability of synthetic and semi-synthetic heparin mimetics, which assist in treating various types of cancer, coagulation and inflammatory diseases, is anticipated to bolster the market growth in the upcoming years.

5. Report Description Report Description and Highlights Market Summary: Breakup by product Type: • Unfractionated • Low molecular weight heparin • Ultra-low molecular weight heparin Breakup by Source: • Bovine • Porcine Breakup by Distribution Channel: • Hospital pharmacies • Retail pharmacies • Drug stores • Online stores

6. Report Description Report Description and Highlights Breakup by Mode: • Oral • Parenteral Breakup by Region: • North America • Europe • Asia Pacific • Latin America • Middle East and Africa Furthermore, some of the leading biopharmaceutical companies are increasing their budget for research and development (R&D) to improve the therapeutic potential of heparin and reduce its side- effects.

7. Report Description Report Description and Highlights Breakup by Application: • Atrial fibrillation and heart attack • Stroke • Deep vein thrombosis • Pulmonary embolism Breakup by End-Use: • Hospitals • Clinics • Homecare settings • Ambulatory surgical centers On account of the aforementioned factors, the market is expected to witness moderate growth during 2021-2026.

8. Report Description and Highlights Report Description Competitive Landscape With Keyplayer: • GlaxoSmithKline Plc • Shenzhen Hepalink Pharmaceutical Co. Ltd • Pfizer Inc. • LEO Pharma A/S • Sanofi S.A. • Dr. Reddy’s Laboratories Ltd. • Teva Pharmaceutical Industries Ltd. • Aspen Holdings • LEO Pharma A/S • Baxter International Inc. • Hebei Changshan Biochemical Pharmaceutical Co. Ltd. • Sandoz International GmbH • Opocrin S.p.A. • Sichuan Deebio Pharmaceutical Co. Ltd. • Dongying Tiandong Pharmaceutical Co. Ltd. View Report TOC, Figures and Tables : https://www.imarcgroup.com/heparin-market

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com